Home Health Certification in Federal Fraud Cases: OASIS, Homebound Status, Face-to-Face Encounter
Home Health Certification Is a Federal Enforcement Priority
On April 15, 2026, the Vice President’s Task Force to Eliminate Fraud announced the suspension of 447 hospice providers and 23 home health agencies in Los Angeles. The total suspected fraud exceeds $600 million. That figure represents a 539% increase from the 70 provider suspensions reported at the beginning of April, when DOJ arrested eight defendants in Operation Never Say Die. Federal officials have stated the numbers will continue to grow.
The 23 home health agency suspensions are significant. CMS is not drawing a distinction between hospice and home health billing anomalies in its enforcement posture. Home health agencies in Los Angeles and nationwide are subject to the same data-driven scrutiny, the same payment suspension authority under 42 C.F.R. section 405.371, and the same 15-day rebuttal timeline that applies to hospice providers.
The home health certification process is the foundation of every Medicare home health claim. Every dollar a home health agency bills to Medicare depends on a chain of regulatory requirements: a face-to-face encounter between a qualifying practitioner and the patient, a comprehensive OASIS assessment at the start of care, a physician-established plan of care on the CMS-485, and a physician certification attesting to homebound status and the need for intermittent skilled services. When any link in that chain is deficient, every claim built on it is potentially false.
Federal prosecutors know this. So does CMS.
In 2025, DOJ’s Health Care Fraud Unit charged 194 individuals in cases involving more than $15 billion in intended losses. The 2025 National Health Care Fraud Takedown resulted in criminal charges against 324 defendants across 50 federal districts. Home health agencies were among the targets. CMS reported that insufficient documentation accounted for 51.4% of improper payments for home health services during the 2024 reporting period. Medical necessity accounted for another 33.7%.
Those numbers represent billions of dollars in claims that CMS determined lacked adequate support in the certification record. A home health agency that fails the certification process at scale is not just losing an audit. It is generating the statistical footprint that triggers a federal criminal investigation.
The Face-to-Face Encounter Requirement
The face-to-face encounter is the first step in the certification chain. It is a statutory prerequisite to Medicare payment for home health services. Congress added this requirement through Section 6407 of the Affordable Care Act with one stated purpose: to reduce fraud by ensuring that a physician or qualified practitioner actually examines the patient before home health services begin.
The regulatory framework is codified at 42 C.F.R. section 424.22(a)(1)(v). A face-to-face encounter related to the primary reason the patient requires home health services must occur no more than 90 days before the start of care or within 30 days after the start of care. The encounter must be performed by the certifying physician, by a physician with hospital privileges who treated the patient in an acute or post-acute facility, or by a nurse practitioner or clinical nurse specialist working in collaboration with the certifying physician. See 42 C.F.R. section 424.22(a)(1)(v)(A).
The encounter documentation must be signed and dated by the person who performed it. It must be a separate and distinct section of the certification or an addendum to it. CMS does not require a specific form, but the documentation must include the date of the encounter and must be clearly titled. See Medicare Benefit Policy Manual, Chapter 7, Section 30.5.1.1. The encounter must be related to the primary reason the patient requires home health services, although CMS guidance clarifies that the encounter diagnosis does not have to match the home health diagnosis exactly if another clinical condition discovered during the encounter forms the basis for the skilled need.
Where the Face-to-Face Encounter Becomes a Criminal Issue
The face-to-face requirement is a condition of payment. Not a coverage criterion. CMS has drawn this distinction explicitly. An Advance Beneficiary Notice may not be used to transfer liability to a beneficiary when the face-to-face requirement is not met, because it is a technical payment requirement, not a service coverage question. When a home health agency bills Medicare for services without a qualifying encounter, the claim was never eligible for payment.
Federal prosecutors use this distinction to build healthcare fraud charges under 18 U.S.C. section 1347. The theory is direct. An agency that systematically bills Medicare without valid face-to-face encounters is submitting claims it knows are not eligible for payment.
The most common face-to-face failures that generate criminal exposure are specific. Encounters that never occurred but were documented as having occurred. Encounters performed outside the 90-day or 30-day window. Encounters unrelated to the primary reason for home health services. Encounters performed by practitioners who did not meet the regulatory qualifications under section 424.22(a)(1)(v)(A). And encounters where the physician signed the documentation without having seen the patient, relying instead on information supplied by the home health agency.
Certifying physicians face direct criminal exposure. A physician who signs a certification attesting to a face-to-face encounter that did not occur, or that the physician knows was deficient, can be charged under 18 U.S.C. section 1035 for false statements relating to healthcare matters, in addition to healthcare fraud and conspiracy charges under 18 U.S.C. sections 1347 and 1349.
The OASIS Assessment and Its Role in Medicare Reimbursement
After the face-to-face encounter, the next step in the certification chain is the OASIS assessment at the start of care. The Outcome and Assessment Information Set is the standardized patient assessment instrument required by CMS for all Medicare home health patients. The regulatory mandate is codified at 42 C.F.R. section 484.55. The home health agency must complete a comprehensive OASIS assessment at admission, at each 60-day recertification, upon any significant change in condition, at transfer, and at discharge.
OASIS collects granular clinical data across dozens of standardized items. It measures the patient’s ability to perform specific activities of daily living: bathing, dressing, toileting, transferring, and ambulation. It captures cognitive function, pain levels, wound status, medication management capacity, and risk for hospitalization. The assessment must be completed by a registered nurse or, if only therapy services are ordered, by the appropriate therapist. Only one clinician may complete or make changes to a given OASIS assessment.
OASIS data directly determines Medicare reimbursement. Under the Patient-Driven Groupings Model, implemented January 1, 2020, CMS uses OASIS items along with claims data to classify each 30-day period of care into one of 432 case-mix groups. Classification depends on five factors: clinical condition category, admission source, episode timing, functional impairment level, and comorbidity adjustment. The functional impairment level is derived from OASIS items that score activities of daily living and hospitalization risk. Higher acuity scores produce higher case-mix weights and larger Medicare payments per 30-day period. This direct connection between OASIS scoring and payment is what makes the OASIS assessment a focal point for federal fraud investigations.
OASIS Upcoding: The Government’s Prosecution Theory
The government’s theory in OASIS upcoding cases is specific. Clinicians inflated functional limitation scores on OASIS items to push patients into higher-paying PDGM case-mix groups. A patient who bathes independently is scored as needing assistance. A patient who ambulates with a cane is scored as requiring a wheelchair. A patient with intact cognition is scored as having moderate impairment. Each inflation moves the patient from one case-mix group to another. The payment difference between adjacent groups can be hundreds of dollars per 30-day period. Across hundreds of patients and multiple episodes, the aggregate overpayment reaches millions.
DOJ’s Health Care Fraud Data Fusion Center uses algorithmic analysis to identify agencies with statistically improbable OASIS scoring patterns. The analytics flag agencies where a disproportionate percentage of patients score at the highest functional limitation levels compared to peer agencies in the same geographic market. They flag agencies whose OASIS scores diverge sharply from scores assigned to the same patients by hospitals, skilled nursing facilities, or prior home health providers within a short timeframe. They flag individual clinicians whose scoring patterns deviate from every other clinician at the same agency. These data-driven red flags initiate the investigations that lead to grand jury subpoenas and federal indictments.
The Defense Pressure Point: OASIS Scoring Is Clinical Judgment
OASIS scoring is not a mechanical exercise. It requires direct clinical observation, patient interview, and professional judgment applied to standardized but inherently subjective assessment items. Two competent registered nurses assessing the same patient on the same day can arrive at materially different scores on items like M1830 (bathing), M1840 (toilet transferring), or M1860 (ambulation). CMS acknowledges this. The OASIS guidance instructs clinicians to score based on the patient’s condition at the time of assessment, using direct observation and clinical reasoning.
This subjectivity is the critical defense tool. A patient who walks to the bathroom independently on a good day may be unable to do so safely on the day of the assessment due to pain, fatigue, or medication effects. A patient who reports dressing independently may require 15 minutes and multiple rest breaks to complete the task. A patient assessed in the morning may present differently than the same patient assessed in the afternoon. These distinctions are clinically real. They produce legitimate scoring differences. They are not fraud.
Defense counsel challenges OASIS upcoding allegations by retaining expert home health clinicians who review the OASIS assessments alongside the contemporaneous skilled nursing visit notes, medication records, and therapy evaluations. The expert demonstrates that the scores were defensible based on the patient’s presentation at the time of the assessment. The defense also examines whether the government’s statistical comparison accounts for legitimate clinical differences between patient populations. An agency that specializes in post-surgical orthopedic patients or patients with advanced neurodegenerative conditions will produce higher functional limitation scores than a general home health agency serving a lower-acuity census. That is a case-mix difference. It is not evidence of fraud.
The Plan of Care and Physician Certification
The OASIS assessment generates the clinical data that drives the plan of care. The plan of care is the operational document governing every home health episode. Under 42 C.F.R. section 409.43, a physician must establish a plan of care that specifies the services needed, the frequency and duration of visits, and the clinical rationale for each service. The plan of care is typically documented on the CMS-485, the Home Health Certification and Plan of Care form. The physician must review and sign the CMS-485. A plan of care may not be established or reviewed by any physician who has a financial relationship with the home health agency. See 42 C.F.R. section 424.22(d)(1).
The physician certification that accompanies the plan of care is codified at 42 C.F.R. section 424.22(a)(1). The certifying physician must attest to five elements: the patient needs intermittent skilled nursing care, physical therapy, or speech-language pathology services as defined in 42 C.F.R. section 409.42(c); the patient is confined to the home; a plan of care has been established and will be periodically reviewed; the services will be furnished while the patient is under the care of a physician; and a qualifying face-to-face encounter has occurred within the required timeframe.
Recertification is required at least every 60 days for continuous home health care under section 424.22(b). The recertifying physician must indicate the continuing need for skilled services and estimate how much longer the services will be required. Each recertification generates a new 30-day billing period under PDGM. Each period carries independent fraud exposure if the underlying eligibility criteria are not met.
Certification Failures That Generate Criminal Charges
Federal prosecutors charge physicians and home health operators when certifications are signed without clinical basis. The patterns are specific. Physicians who sign stacks of CMS-485 forms for patients they have never examined. Physicians who certify homebound status based solely on information provided by the home health agency’s intake coordinator, without independent clinical assessment. Physicians who sign certifications weeks or months after the start of care, backdating the signature to create the appearance of compliance. And physicians who receive per-certification compensation from the home health agency.
The compensation arrangement is the fulcrum. When a physician receives payment from a home health agency that correlates to the number of CMS-485 forms signed, the Anti-Kickback Statute, 42 U.S.C. section 1320a-7b, applies. The payment is remuneration to induce certifications. The Anti-Kickback Statute functions as a plus factor: it converts every claim generated from a kickback-tainted certification into a false claim under the False Claims Act. Both the physician and the agency face criminal exposure under 18 U.S.C. section 1347, 42 U.S.C. section 1320a-7b, and 18 U.S.C. section 1349.
Homebound Status Certification
Homebound status is an element of the physician certification under section 424.22(a)(1)(ii). But it is the single most contested eligibility element in federal home health fraud cases. It warrants separate analysis because it is the element that generates the most defense opportunities at trial.
Medicare home health services are available only to patients who are confined to the home. This is a statutory eligibility requirement under Sections 1814(a) and 1835(a) of the Social Security Act. CMS defines homebound status through a two-part test set forth in the Medicare Benefit Policy Manual, Chapter 7, Section 30.1.1.
The first criterion requires that the patient have a condition, due to illness or injury, that restricts the ability to leave home. Specifically, the patient must need the aid of supportive devices such as crutches, canes, wheelchairs, or walkers; require special transportation; require the assistance of another person to leave; or have a condition such that leaving home is medically contraindicated.
The second criterion requires that the patient have a normal inability to leave home and that leaving home require a considerable and taxing effort. Both criteria must be met.
A patient may leave home for medical treatment and for short, infrequent absences for nonmedical reasons. Attending religious services or adult day care does not automatically disqualify a patient. CMS instructs that the standard evaluates the patient’s overall condition over a period of time rather than isolated events. A patient who has multiple medical appointments in a single week and leaves home more frequently during that period does not necessarily lose homebound status.
Homebound Status as a Criminal Fraud Theory
Federal investigators build homebound fraud cases through specific investigative techniques. HHS-OIG agents conduct physical surveillance of patients at their homes and in the community. They document patients at grocery stores, gyms, churches, shopping malls, and social events. They photograph patients walking unassisted across parking lots. They subpoena social media accounts and identify photographs of travel, outdoor activities, and family events that contradict the homebound certification.
They interview patients directly. They ask specific questions: How often do you leave home? Do you drive? Do you go to the grocery store? Do you attend social events? They interview family members and neighbors. They compare the patient’s statements about daily activities to the OASIS functional limitation scores and the homebound certification in the CMS-485.
The surveillance photographs and patient statements are the government’s trial exhibits. They are powerful. A photograph of a Medicare beneficiary walking unassisted into a shopping center, juxtaposed with an OASIS assessment that scores the same patient as requiring maximum assistance with ambulation, is a devastating piece of evidence at trial.
The Defense Pressure Point: Homebound Is a Clinical Determination, Not a Surveillance Snapshot
Homebound status is not a bright-line test. It is a clinical determination that involves professional judgment about a patient’s overall condition over the course of an episode. CMS itself recognizes that a patient’s condition fluctuates. A patient who attends a grandchild’s graduation is not automatically non-homebound. A patient photographed at a grocery store with the assistance of a family member is not automatically non-homebound. The question under the CMS standard is whether leaving the home required a considerable and taxing effort given the patient’s overall medical condition.
Defense counsel retains geriatric medicine specialists, physical medicine and rehabilitation physicians, and home health nursing experts to contextualize the surveillance evidence. The expert testimony establishes that a snapshot of a patient on a single day does not capture the clinical reality of the entire episode. A patient with congestive heart failure classified as NYHA Class III may have a day with lower symptom burden. That does not mean the patient is not homebound on the other 29 days of the 30-day period. The clinical record, not the surveillance photograph, is the appropriate measure of homebound status.
Local Coverage Determinations and Their Role in Criminal Cases
Local Coverage Determinations are coverage rules established by Medicare Administrative Contractors. They define the conditions under which specific home health services are covered in a particular MAC jurisdiction. For home health, LCDs address issues such as the frequency and duration of skilled nursing visits, the medical necessity criteria for specific therapy services, and documentation requirements for particular clinical conditions. The applicable LCDs for each jurisdiction are accessible through the CMS Medicare Coverage Database.
LCDs are not statutes. They are not regulations. They are administrative guidelines that vary by MAC and change over time. A provider operating in a Palmetto GBA jurisdiction is subject to different LCD requirements than a provider operating in a CGS Administrators jurisdiction.
LCDs in the Government’s Fraud Theory
Federal prosecutors use LCD violations as circumstantial evidence of fraudulent intent. The theory is that a provider who consistently bills outside LCD parameters knew or should have known the services would not be covered. Repeated LCD violations, combined with high billing volume, support an inference that the provider was billing services it knew Medicare would deny if the claims were reviewed.
This theory has limits. An LCD violation supports recoupment of the overpayment. It is a basis for a civil monetary penalty or a False Claims Act action. It does not, standing alone, establish the specific intent required for criminal healthcare fraud. The distinction between a billing error and a federal crime is willfulness under 18 U.S.C. section 1347. A provider who misunderstands an LCD requirement, or who applies clinical judgment that differs from the MAC’s coverage policy, has not committed a crime.
The Defense Pressure Point: Ambiguity Defeats Willfulness
LCDs are often ambiguous. They use clinical terms that admit multiple reasonable interpretations. They change during the relevant billing period. Different MACs apply different coverage rules to the same CPT codes and service descriptions. A provider operating across MAC boundaries may apply the wrong LCD to the wrong claims. These are compliance failures. They are not evidence of criminal intent.
Defense counsel challenges the government’s reliance on LCD violations by demonstrating that the provider made documented, good-faith efforts to comply with applicable coverage rules. Where an LCD is ambiguous on its face, that ambiguity favors the provider and undercuts any inference of knowing fraud. Defense counsel also examines whether the government has applied superseded LCDs or retroactively imposed coverage rules that were not in effect during the billing period at issue. An LCD that was adopted after the charged conduct is not evidence that the provider knew the billing was non-compliant at the time.
Trial Proof: Attacking Beneficiary Testimony
Federal home health fraud cases go to trial more often than many defendants expect. DOJ’s Health Care Fraud Unit took 17 healthcare fraud cases to trial in 2025 alone. When a home health case reaches trial, the government’s proof depends heavily on the testimony of Medicare beneficiaries. The beneficiaries are the patients whose names appear on the CMS-485 certifications, the OASIS assessments, and the skilled nursing visit notes. Their testimony is the primary mechanism by which the government proves that the clinical information in those documents is false.
This makes beneficiary cross-examination one of the most consequential phases of a home health fraud trial.
The Government’s Dependence on Beneficiary Witnesses
In a home health fraud trial, the government must prove beyond a reasonable doubt that the certifications were false. The CMS-485 says the patient was homebound. The OASIS assessment scores the patient at specific functional limitation levels on items like M1830, M1840, and M1860. The skilled nursing visit notes document clinical findings consistent with the plan of care. The government’s theory is that those records do not reflect reality.
But the records were created by licensed clinicians. The nurses documented what they observed. The physicians signed certifications based on clinical information. To prove the records are false, the government puts the beneficiary on the witness stand and elicits testimony that directly contradicts the medical record. The beneficiary testifies: I was not homebound. I did not need help bathing. I could walk without assistance. I did not have the symptoms the nurse documented.
That testimony is the government’s proof of falsity. Without it, the government is left arguing that licensed clinicians fabricated clinical findings with no corroboration from the patient. Beneficiary testimony is therefore indispensable to the prosecution’s case. It is also vulnerable.
Beneficiaries Who Lied to Their Own Clinicians
In many federal home health fraud cases, the beneficiaries were recruited into the scheme through kickback arrangements. A marketer approached them at a community center, a grocery store, a church, or their apartment building. The marketer offered cash, gift cards, prepaid debit cards, groceries, or other inducements. The beneficiary agreed to enroll. The marketer scheduled the face-to-face encounter and coordinated the first home visit.
Here is the problem the government must confront at trial. Those beneficiaries lied to the clinicians.
The patient told the registered nurse during the OASIS start-of-care assessment that leaving home was difficult. The patient reported needing assistance with bathing and toileting. The patient described pain levels, fatigue, shortness of breath, and functional limitations consistent with homebound status and a high functional impairment score. The clinician documented what the patient reported. The clinician assessed the patient based on the self-reported symptoms, the patient’s demonstrated performance during the visit, and clinical observation. The clinician scored the OASIS items accordingly.
The beneficiary’s motivation for lying was the kickback payment. The marketer told the beneficiary to appear sicker than they were. The marketer coached the beneficiary on what to say to the nurse. But the clinician did not know about the kickback. The marketer did not disclose it. The beneficiary did not disclose it. The clinician received a patient who reported symptoms consistent with home health eligibility, assessed the patient in good faith, and documented those findings in the medical record.
The Defense Pressure Point: The Undisclosed Kickback Contaminates the Medical Record
This factual pattern creates a powerful defense for the clinician, the certifying physician, and the agency operator. The government’s trial theory depends on proving that the defendant knew the certifications were false. But if the patient lied to the clinician about symptoms and functional limitations because the patient was receiving undisclosed kickback payments, and the clinician did not know about the kickback arrangement, the clinician’s documentation was based on false information provided by the patient.
That is not fraud by the clinician. That is fraud on the clinician.
Cross-examination of the beneficiary must establish specific facts in a specific sequence. First, the beneficiary received something of value from a marketer or recruiter in exchange for enrolling in home health services. Second, the beneficiary did not disclose the kickback to the nurse who performed the OASIS assessment. Third, the beneficiary did not disclose the kickback to the certifying physician who signed the CMS-485. Fourth, the beneficiary reported symptoms or limitations to the clinician that the beneficiary now admits were not true. Fifth, the clinician had no independent means of verifying that the patient was fabricating subjective complaints like pain, fatigue, dyspnea on exertion, or difficulty performing activities of daily living.
When these facts are established through cross-examination, the government’s own witness has demonstrated that the false information in the medical records originated with the patient, not with the defendant. The certifying physician relied on what the patient reported. The OASIS clinician scored the patient based on what the patient described and demonstrated. The documentation was a product of the beneficiary’s deception, not the provider’s fraud.
How Kickback Payments Corrupt the Clinical Encounter
The Anti-Kickback Statute exists because kickbacks corrupt medical decision-making. In home health fraud cases, that corruption flows in both directions. Kickbacks paid to marketers corrupt the referral process. But kickbacks paid to beneficiaries corrupt the clinical encounter itself.
A patient receiving $200 per month in cash to remain enrolled in home health services has a financial incentive to exaggerate symptoms at every skilled nursing visit. That patient reports that leaving home is taxing. That patient demonstrates difficulty with ambulation during the visit. That patient describes needing assistance with bathing, dressing, and transfers. Each of these self-reports drives the OASIS functional limitation scores, supports the homebound certification on the CMS-485, and sustains the plan of care. The entire certification chain is built on clinical data that is tainted by an undisclosed financial incentive the clinician does not know about.
Defense counsel demonstrates at trial that the kickback arrangement contaminated the source data on which the clinical documentation rests. The OASIS assessment is only as reliable as the patient’s self-report and in-visit presentation. When that self-report was purchased by a kickback, the medical record reflects the kickback, not the patient’s true clinical condition.
Impeaching the Government’s Cooperating Beneficiary
Beneficiary witnesses in home health fraud trials are frequently cooperating witnesses. They have entered plea agreements, non-prosecution agreements, or immunity agreements with the government in exchange for their testimony. They have a powerful motive to testify consistently with the government’s theory. Cross-examination must expose that motive.
Effective cross-examination establishes that the beneficiary is testifying to avoid their own criminal prosecution. That the beneficiary personally received kickback payments they never reported to the IRS. That the beneficiary affirmatively misrepresented their condition to licensed medical professionals. That the beneficiary’s trial testimony today directly contradicts the statements they made to nurses, therapists, and physicians during the home health episodes. That the beneficiary’s cooperation agreement requires them to testify consistently with the government’s version of events.
Every inconsistency between the beneficiary’s trial testimony and the contemporaneous medical record is a defense exhibit. Every undisclosed kickback payment is evidence of a motive to lie to clinicians. Every cooperation agreement is an incentive to tell the government what it wants to hear.
This is trial work that requires counsel who understands how DOJ prosecutors construct the trial proof in a home health fraud case, how the face-to-face encounter documentation, the OASIS assessment, the CMS-485 certification, and the skilled nursing visit notes interrelate as a documentary chain, and how to use the government’s own cooperating witnesses to prove that the defendant acted in good faith. For a comprehensive overview of the federal enforcement landscape and defense strategies in home health fraud cases, see the firm’s home health fraud enforcement and defense analysis.
How a Federal Home Health Fraud Case Is Built
Federal home health fraud investigations typically begin with one of three triggers. The first is a data analytics flag from the Health Care Fraud Data Fusion Center or a CMS Program Integrity contractor that identifies billing outliers. The second is a qui tam complaint filed under the False Claims Act, 31 U.S.C. section 3730, by a whistleblower. Former nurses, therapists, billing staff, and agency administrators are the most common relators. The third is a referral from a Unified Program Integrity Contractor or Recovery Audit Contractor following a targeted claims review.
Once the investigation opens, federal agents reconstruct the certification chain for every patient billed to Medicare. They compare the face-to-face encounter documentation to the physician certification on the CMS-485. They compare the OASIS scores to clinical records from the referring hospital, the patient’s primary care physician, and any prior or subsequent home health provider. They interview patients, family members, and former employees. They subpoena bank records and financial records to identify kickback payments to marketers, recruiters, and certifying physicians. They issue grand jury subpoenas for the agency’s complete OASIS data files, which CMS requires agencies to transmit electronically.
The government builds its loss calculation from the claims data. Every claim submitted without a valid face-to-face encounter, without a supported homebound certification, or with inflated OASIS scores is treated as a false claim. The aggregate of those claims becomes the intended loss figure in the indictment. That figure directly affects the advisory sentencing range under the U.S. Sentencing Guidelines, section 2B1.1. Loss amounts in home health cases routinely reach tens of millions of dollars, producing advisory guideline ranges well above 10 years of imprisonment.
The firm’s attorneys know how federal prosecutors build healthcare fraud cases because they built them.
Scott Armstrong served as an Assistant Chief in the DOJ Fraud Section, where he tried four federal home health fraud jury trials in the Southern District of Texas involving more than $57 million in false claims.
Drew Bradylyons served as Chief of the Financial Crimes and Public Corruption Unit in the Eastern District of Virginia and supervised the Healthcare Fraud Unit’s South Florida Strike Force, where he oversaw cases involving more than $1 billion in fraudulent claims.
Frequently Asked Questions
What are the five elements of a Medicare home health certification under 42 C.F.R. section 424.22?
Under 42 C.F.R. section 424.22(a)(1), a physician must certify five elements for Medicare to pay for home health services. First, the patient needs intermittent skilled nursing care, physical therapy, or speech-language pathology services as defined in section 409.42(c). Second, the patient is confined to the home under the homebound standard in Sections 1814(a) and 1835(a) of the Social Security Act. Third, a plan of care has been established and will be periodically reviewed by a physician. Fourth, the services will be furnished while the patient is under the care of a physician. Fifth, a face-to-face encounter related to the primary reason for home health services has occurred no more than 90 days before or 30 days after the start of care. If any element is absent, the claim fails as a condition of payment, not merely as a coverage question.
What is the face-to-face encounter requirement and how does it function as a condition of payment?
Congress added the face-to-face encounter through Section 6407 of the Affordable Care Act to ensure a physician or qualified practitioner examines the patient before home health services begin. Under 42 C.F.R. section 424.22(a)(1)(v), the encounter must occur within 90 days before or 30 days after the start of care. It must be related to the primary reason the patient requires home health services. The encounter may be performed by the certifying physician, a physician who treated the patient in an acute or post-acute setting, or a nurse practitioner or clinical nurse specialist collaborating with the certifying physician. CMS treats this as a condition of payment, not a coverage criterion. An Advance Beneficiary Notice may not be used to shift liability to the patient when the encounter requirement is unmet. See Medicare Benefit Policy Manual, Chapter 7, Section 30.5.1.1.
How does OASIS scoring determine Medicare reimbursement under the Patient-Driven Groupings Model?
Under the PDGM, implemented January 1, 2020, CMS classifies each 30-day period of home health care into one of 432 case-mix groups. Classification depends on five factors: clinical condition category, admission source (institutional vs. community), episode timing (early vs. late), functional impairment level, and comorbidity adjustment. The functional impairment level is derived from OASIS items that score activities of daily living and hospitalization risk, including items M1800 through M1860 and specific risk-assessment items. Higher functional limitation scores produce higher case-mix weights. This connection between OASIS data and payment is the mechanism federal investigators target when alleging upcoding. The OASIS assessment must be completed at admission, every 60 days at recertification, upon significant change in condition, at transfer, and at discharge under 42 C.F.R. section 484.55.
What is the Medicare two-part test for homebound status?
CMS defines homebound status through a two-part test in the Medicare Benefit Policy Manual, Chapter 7, Section 30.1.1, implementing Sections 1814(a) and 1835(a) of the Social Security Act. The first criterion requires a condition, due to illness or injury, that restricts the ability to leave home. This means needing supportive devices, special transportation, another person’s help, or having a medical condition making departure inadvisable. The second criterion requires a normal inability to leave home and that leaving require a considerable and taxing effort. Both criteria must be met. A patient may leave for medical treatment and for short, infrequent nonmedical absences such as religious services, adult day care, or a barber visit. CMS instructs clinicians to evaluate the patient’s condition over a period of time, not based on isolated instances.
Can a certifying physician be charged criminally in a home health fraud case?
Yes. Certifying physicians face direct criminal exposure under multiple statutes. A physician who signs a CMS-485 certification without clinical basis can be charged with healthcare fraud under 18 U.S.C. section 1347, false statements relating to healthcare matters under 18 U.S.C. section 1035, and conspiracy under 18 U.S.C. section 1349. If the physician received compensation from the home health agency tied to the volume of certifications signed, Anti-Kickback Statute charges under 42 U.S.C. section 1320a-7b also apply. Section 424.22(d)(1) prohibits any physician with a financial relationship with the home health agency from establishing or reviewing the plan of care. DOJ routinely names certifying physicians as co-defendants alongside agency operators. Conviction triggers mandatory exclusion from all federal healthcare programs under OIG exclusion authority.
How does the Anti-Kickback Statute convert a home health referral into a false claim?
The Anti-Kickback Statute, 42 U.S.C. section 1320a-7b, prohibits offering, paying, soliciting, or receiving remuneration to induce or reward referrals for services paid by federal healthcare programs. In home health cases, kickback schemes commonly involve cash payments to marketers or recruiters who identify and enroll patients, per-certification compensation to physicians, and payments to hospital discharge planners or skilled nursing facility staff for referrals. The statute functions as a force multiplier in the fraud theory. Every claim generated from a kickback-tainted referral is a false claim because it results from a corrupted referral process. Defense counsel analyzes each compensation arrangement against the OIG Safe Harbor Regulations, including the personal services safe harbor, the employee safe harbor, and the fair market value safe harbor, to determine whether any recognized protection applies.
How does DOJ’s Data Fusion Center identify home health fraud targets?
DOJ’s Health Care Fraud Data Fusion Center, announced during the 2025 Takedown, combines CMS billing data, HHS-OIG investigative data, and AI-driven analytics to identify billing outliers. For home health agencies, the system flags agencies with unusually high OASIS acuity scores relative to peer agencies in the same MAC jurisdiction, therapy utilization rates that deviate from clinical expectations under PDGM, disproportionate numbers of patients scoring at the highest functional limitation levels, rapid patient census growth, and concentrated referral patterns from a single physician or facility. An agency flagged by these analytics typically first receives a UPIC audit or CMS prepayment review notice. That administrative contact can be a precursor to a grand jury subpoena and criminal investigation.
Are LCD violations sufficient to support federal criminal healthcare fraud charges?
No. An LCD violation, standing alone, is a basis for claims recoupment or a civil monetary penalty. It is not a crime. Local Coverage Determinations are administrative guidelines issued by Medicare Administrative Contractors. They vary by jurisdiction and change over time. Criminal healthcare fraud under 18 U.S.C. section 1347 requires proof beyond a reasonable doubt that the provider knowingly and willfully submitted false claims as part of a scheme to defraud. A pattern of repeated LCD violations at high volume can support an inference of intent when combined with other evidence, such as kickback payments, falsified records, or admissions by co-conspirators. But the LCD violation itself does not establish the willfulness element. Where an LCD is ambiguous or where the provider applied a superseded LCD in good faith, the ambiguity undermines the government’s ability to prove criminal intent.
What is the defense against OASIS upcoding allegations in a federal prosecution?
OASIS scoring requires clinical judgment applied to standardized but inherently subjective assessment items. Two competent registered nurses assessing the same patient can arrive at different scores on items like M1830 (bathing), M1840 (toilet transferring), and M1860 (ambulation) based on the patient’s presentation at the time of the visit. The defense centers on demonstrating that the scores were clinically defensible when recorded. Defense counsel retains expert home health clinicians to review each OASIS assessment alongside contemporaneous skilled nursing notes, therapy evaluations, medication records, and the patient’s medical history. The defense also challenges the government’s peer-comparison data by identifying legitimate case-mix differences. An agency serving post-surgical orthopedic patients or patients with advanced COPD or CHF will produce higher functional limitation scores than a general-population agency. The government must prove the clinician intended to inflate scores to increase reimbursement. Good-faith clinical judgment is not fraud.
How is beneficiary testimony challenged at a federal home health fraud trial?
The government relies on beneficiary testimony to prove that the information in the medical records is false. Defense counsel cross-examines beneficiaries to establish specific impeachment facts: that the beneficiary received undisclosed kickback payments from a marketer or recruiter in exchange for enrollment; that the beneficiary affirmatively misrepresented symptoms, pain levels, and functional limitations to the nurse who performed the OASIS assessment; that the beneficiary did not disclose the kickback to the certifying physician or the OASIS clinician; and that the beneficiary’s trial testimony directly contradicts statements made to medical professionals during home visits documented in the clinical record. When a beneficiary fabricated symptoms to continue receiving kickback payments, the false information in the medical record originated with the patient, not the provider. Beneficiaries who have entered cooperation agreements with the government also carry a motive to testify consistently with the prosecution’s theory, which is a separate basis for impeachment.
What role do qui tam whistleblowers play in federal home health fraud investigations?
Whistleblowers are a primary trigger for federal home health fraud investigations. Under the False Claims Act, 31 U.S.C. section 3730, any person with knowledge of fraud against the federal government may file a qui tam lawsuit on behalf of the government. The suit is filed under seal in federal court and served on DOJ, which investigates the allegations before deciding whether to intervene. If the government intervenes, the relator receives between 15% and 25% of the recovery. If the government declines, the relator may proceed independently and receives between 25% and 30%. Former registered nurses, physical therapists, occupational therapists, billing coordinators, and agency administrators are the most common relators in home health cases. Their inside knowledge of certification practices, OASIS scoring protocols, marketer compensation arrangements, and physician relationships provides the factual foundation for many federal investigations and grand jury subpoenas.
What sentencing exposure does a federal home health fraud conviction carry?
Healthcare fraud under 18 U.S.C. section 1347 carries a statutory maximum of 10 years per count, or 20 years if the offense results in serious bodily injury. Anti-Kickback Statute violations under 42 U.S.C. section 1320a-7b carry up to 10 years per count. Conspiracy under 18 U.S.C. section 1349 carries the same maximum as the underlying offense. Money laundering under 18 U.S.C. section 1956 carries up to 20 years per count. The U.S. Sentencing Guidelines, section 2B1.1, calculate the advisory range based primarily on intended loss amount, number of victims, use of sophisticated means, role in the offense, and obstruction. Loss amounts in home health cases routinely reach tens of millions of dollars, producing advisory guideline ranges exceeding 10 years. Conviction also triggers mandatory exclusion from all federal healthcare programs, which effectively ends a healthcare career. For a detailed analysis of the federal charges and defense strategies in home health fraud cases, see the firm’s home health fraud enforcement and defense overview.
